Author:
Seifert Frank,Todorov Dimiter K.,Hutter Karl-J.,Zeller W. Jens
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Oncology,General Medicine
Reference25 articles.
1. Arnaudov I, Georgiev G, Petrov M, Serbesova M (1986) The effect of the Bulgarian antineoplastic agent thaliblastine in the treatment of patients with malignant lymphomas. In: Proceedings of the 1st International Symposium on Clinical Pharmacology, Sofia (abstract 13)
2. Broder L, Carter S (1971) Thalicarpine (NSC-68075) Clinical brochure. National Cancer Institute, Bethesda, MA
3. Chen G, Zeller WJ (1990) In vitro investigations of induction and reversal of cisplatin resistance in a rat ovarian tumor cell line. J Cancer Res Clin Oncol 116: 443?447
4. Chen G, Hutter KJ, Bullerdiek J, Zeller WJ (1991) Karyotypic change from heteroploidy to near diploidy associated with development of cisplatin resistance in a rat ovarian tumour cell line. J Cancer Res Clin Oncol 117: 539?542
5. Chen G, Todorov DK, Zeller WJ (1992) Antitumor activity of thaliblastine (NSC-68075) in experimental ovarian tumor cell lines sensitive and resistant to cisplatin. Cancer Lett 62: 173?177
Cited by
8 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献